Log In
Print
BCIQ
Print
Print this Print this
 

rindopepimut (CDX-110) (formerly PF-04948568)

Also known as: formerly ALT-110

  Manage Alerts
Collapse Summary General Information
Company Celldex Therapeutics Inc.
DescriptionVaccine targeting epidermal growth factor (EGF) receptor (EGFR) variant III (EGFRvIII)
Molecular Target Epidermal growth factor variant III (EGFRvIII)
Mechanism of ActionVaccine
Latest Stage of DevelopmentPhase III
IndicationBrain cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today